Does GABAPENTIN Cause Interstitial lung disease? 34 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Interstitial lung disease have been filed in association with GABAPENTIN (Gabapentin). This represents 0.1% of all adverse event reports for GABAPENTIN.
34
Reports of Interstitial lung disease with GABAPENTIN
0.1%
of all GABAPENTIN reports
2
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From GABAPENTIN?
Of the 34 reports, 2 (5.9%) resulted in death, 10 (29.4%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does GABAPENTIN Cause?
Drug ineffective (10,914)
Drug hypersensitivity (6,833)
Off label use (6,729)
Drug ineffective for unapproved indication (5,231)
Product use in unapproved indication (4,919)
Toxicity to various agents (4,839)
Completed suicide (4,111)
Dizziness (4,107)
Somnolence (3,798)
Fatigue (3,791)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which GABAPENTIN Alternatives Have Lower Interstitial lung disease Risk?
GABAPENTIN vs GABAPENTIN ENACARBIL
GABAPENTIN vs GADAVIST
GABAPENTIN vs GADOBENATE DIMEGLUMINE
GABAPENTIN vs GADOBUTROL
GABAPENTIN vs GADODIAMIDE